Your browser doesn't support javascript.
loading
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Garcia-Olmo, Damián; Gilaberte, Inmaculada; Binek, Matthias; D Hoore, André J L; Lindner, Dirk; Selvaggi, Francesco; Spinelli, Antonino; Panés, Julian.
Affiliation
  • Garcia-Olmo D; Universidad Autónoma de Madrid, Fundación Jiménez Díaz, University Hospital, Madrid, Spain.
  • Gilaberte I; Takeda Pharmaceuticals S.L., Madrid, Spain.
  • Binek M; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • D Hoore AJL; Universitair Ziekenhuis Leuven, Leuven, Belgium.
  • Lindner D; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Selvaggi F; Colon and Rectal Surgery Unit, Department of Advanced Medical and Surgery Sciences, Luigi Vanvitelli University, Naples, Italy.
  • Spinelli A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Panés J; IRCCS Humanitas Research Hospital, Division of Colon and Rectal Surgery, Rozzano Milan, Italy.
Dis Colon Rectum ; 65(5): 713-720, 2022 05 01.
Article in En | MEDLINE | ID: mdl-34890373
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Crohn Disease / Mesenchymal Stem Cells Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Crohn Disease / Mesenchymal Stem Cells Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Year: 2022 Type: Article